off-label use of glp-1 agonists for obesity in 2016 The Weight-loss Effect GLP-1RAs Glucagon-Like Peptide-1 Receptor Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials Weight Reduction with GLP-1 Agonists

doi: 10.1016/S2213-8587(15)00436-2 [DOI] [PubMed] [Google Scholar] 59

Bariatric surgery in proper candidates can be effective and safe for improving steatosis, inflammation and to a lesser degree liver fibrosis and must be carefully evaluated in individuals with cirrhosis [33, 34]

In the consumer staples sector, Anheuser Busch InBev and The Hershey Company have seen their stocks decline as investors start to ponder what demand could look like for their various products over the long term as these companies market products that are generally unhealthy for consumption

Cardiac rehabilitation, lifestyle changes, and medications are critical for secondary prevention

The presence of NAFLD increases the incidence of type 2 diabetes and accelerates the development of complications in type 2 diabetes [5]